PGT-SR (testing for structural chromosome rearrangements)
Photo: ksblack99 · CC0Overview
For couples in which one partner carries a balanced translocation, inversion or similar structural rearrangement, embryos are tested to select those without an unbalanced chromosome set, to reduce miscarriage. It is run under the same JSOG framework as PGT-A.
Time needed / downtime
Same as PGT-A.
Reference price
Price on request
Reference range from published sources. Actual cost is set by the facility's quote.
Facilities offering this (3)



Good to know
How NIPT certification works in Japan
Since July 2022, facilities offering NIPT are certified by the Committee for the Operation of the Prenatal Testing Certification System set up under the Japanese Association of Medical Sciences (JAMS). Hospitals are certified either as core facilities (kikan shisetsu) or as linked facilities (renkei shisetsu) that work with a core facility, and laboratories that analyse samples are certified separately. Certification must be renewed every five years, and applications are reviewed twice a year.
Source: jams-prenatal.jp ↗What certified facilities test and how
At certified facilities NIPT covers only trisomy 21 (Down syndrome), trisomy 18 and trisomy 13. Genetic counseling is required before the test, and a positive result is treated as a screening finding that must be confirmed by amniocentesis or chorionic villus sampling. In fiscal 2022 there were 169 certified core facilities, 206 linked facilities and 27 certified laboratories, which performed 20,639 tests.
Source: jams-prenatal.jp ↗Concerns about NIPT outside the certification system
A health ministry expert committee noted that NIPT offered by non-certified facilities had increased and that in some cases adequate genetic counseling was not provided. The national framework also states that prenatal testing should not be carried out or promoted as uniform mass screening. The JAMS committee recommends that pregnant women take NIPT at certified facilities and publishes information materials, including an English explanation leaflet. Testing at non-certified facilities falls outside this framework.
Source: mhlw.go.jp ↗Fetal sex determination in Japanese prenatal testing
Certified NIPT in Japan is limited to the three trisomies, so fetal sex chromosomes are not among the items reported. Under the guidance of the Japan Society of Obstetrics and Gynecology (JSOG), sex determination of embryos or fetuses is accepted only where it is needed for a serious sex-linked (X-linked) genetic disease, and sex selection for non-medical reasons is not permitted. JSOG's guidance binds its members; Japan has no specific statute on it.
Source: jstage.jst.go.jp ↗JSOG eligibility for PGT-A and PGT-SR
PGT-A may be performed only at facilities approved by JSOG, which must register each case and report results. Its rules limit PGT-A to infertile couples with repeated failure of IVF embryo transfer and couples with recurrent miscarriage or stillbirth; couples in which a partner has a confirmed structural chromosome abnormality are handled as PGT-SR. Genetic counseling must be available at the facility or a partner facility.
Source: fujita-hu.ac.jp ↗2025 expansion of PGT-A to women aged 35 and over
In September 2025 JSOG began allowing infertile couples in which the woman is 35 or older to undergo preimplantation testing for chromosome number, in addition to the earlier criteria of repeated IVF failure or recurrent pregnancy loss. Between 2022 and 2024 the society approved 110 of 124 applications for preimplantation diagnosis of genetic disease (PGT-M).
Source: japantimes.co.jp ↗Articles

Prenatal and preimplantation testing in Japan: what NIPT and PGT-A can do
Japan certifies NIPT providers and sets strict conditions for PGT-A. What is and isn't possible, explained.
Updated 2026-11-20 · 16 sources · 6 min readFAQ
How long does PGT-SR (testing for structural chromosome rearrangements) take?
Same as PGT-A.
Where can I get PGT-SR (testing for structural chromosome rearrangements) in Japan?
Facilities accepting international patients include Osaka University Hospital, The University of Tokyo Hospital (Women's Health / Obstetrics), Tokushima University Hospital.


